HCPCS Codes Similar to M1469

HCPCS Codes Similar to “M1469” Code.
Patient has a history of hepatitis b illness or received a hepatitis b surface antigen, hepatitis b surface antibody, or total antibody to hepatitis b core antigen test with a positive result any time before or during the measurement period

G0499 Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result Code added date: 20160928 Code effective date: 20180401 TXT \| PDF \| XML \| JSON	G0298 Hiv antigen/antibody, combination assay, screening Code added date: 20150413 Code effective date: 20150413 TXT \| PDF \| XML \| JSON
G0475 Hiv antigen/antibody, combination assay, screening Code added date: 20150413 Code effective date: 20150413 TXT \| PDF \| XML \| JSON	C9098 Ciltacabtagene autoleucel, up to 100 million autologous b-cell maturation antigen (bcma) directed car-positive t cells, including leukapheresis and dose preparation procedures, per therapeutic dose Code added date: 20220701 Code effective date: 20221001 TXT \| PDF \| XML \| JSON
Q2055 Idecabtagene vicleucel, up to 510 million autologous b-cell maturation antigen (bcma) directed car-positive t cells, including leukapheresis and dose preparation procedures, per therapeutic dose Code added date: 20220101 Code effective date: 20240404 TXT \| PDF \| XML \| JSON	Q2056 Ciltacabtagene autoleucel, up to 100 million autologous b-cell maturation antigen (bcma) directed car-positive t cells, including leukapheresis and dose preparation procedures, per therapeutic dose Code added date: 20221001 Code effective date: 20221001 TXT \| PDF \| XML \| JSON
G0103 Prostate cancer screening; prostate specific antigen test (psa) Code added date: 20000101 Code effective date: 20070101 TXT \| PDF \| XML \| JSON	S3721 Prostate cancer antigen 3 (pca3) testing Code added date: 20120401 Code effective date: 20160101 TXT \| PDF \| XML \| JSON
M1231 Patient receives hcv antibody test with nonreactive result Code added date: 20240101 Code effective date: 20240101 TXT \| PDF \| XML \| JSON	M1232 Patient receives hcv antibody test with reactive result Code added date: 20240101 Code effective date: 20240101 TXT \| PDF \| XML \| JSON
M1233 Patient does not receive hcv antibody test or patient does receive hcv antibody test but results not documented, reason not given Code added date: 20240101 Code effective date: 20240101 TXT \| PDF \| XML \| JSON	G9874 Four total medicare diabetes prevention program (mdpp) core sessions were attended by an mdpp beneficiary under the mdpp expanded model (em). a core session is an mdpp service that: (1) is furnished by an mdpp supplier during months 1 through 6 of the mdpp services period; (2) is approximately 1 hour in length; and (3) adheres to a cdc-approved dpp curriculum for core sessions Code added date: 20180401 Code effective date: 20180401 TXT \| PDF \| XML \| JSON
G9875 Nine total medicare diabetes prevention program (mdpp) core sessions were attended by an mdpp beneficiary under the mdpp expanded model (em). a core session is an mdpp service that: (1) is furnished by an mdpp supplier during months 1 through 6 of the mdpp services period; (2) is approximately 1 hour in length; and (3) adheres to a cdc-approved dpp curriculum for core sessions Code added date: 20180401 Code effective date: 20180401 TXT \| PDF \| XML \| JSON	G9890 Bridge payment: a one-time payment for the first medicare diabetes prevention program (mdpp) core session, core maintenance session, or ongoing maintenance session furnished by an mdpp supplier to an mdpp beneficiary during months 1-24 of the mdpp expanded model (em) who has previously received mdpp services from a different mdpp supplier under the mdpp expanded model. a supplier may only receive one bridge payment per mdpp beneficiary Code added date: 20180401 Code effective date: 20180401 TXT \| PDF \| XML \| JSON